Efficacy of the genetic sonogram in a stepwise sequential protocol for down syndrome screening

Journal of Ultrasound in Medicine

Volumn 32, Issue 9, 2013, Pages 1607-1613

  Shamshirsaz, Alireza A ^a   Ravangard, Samadh F ^a   Turner, Garry ^a   Borgida, Adam ^c   Janicki, Mary Beth ^d   Campbell, Winston A ^a   Zelop, Carolyn ^e   Shamshirsaz, Amirhoushang A ^d   Spiel, Melissa ^a   Prabulos, Anne Marie ^a   Feldman, Deborah ^c   Rodis, John ^d   Ingardia, Charles J ^c   Gurram, Padmalatha ^a   Fuller, Kisti ^a   Fang, Yu M ^c   Benn, Peter ^b   Egan, James F X ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c HARTFORD HOSPITAL   (United States)

^d SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aneuploidy; Antenatal screening; Down syndrome screening; Genetic sonogram; Stepwise sequential

Indexed keywords

RADIOLOGY; ULTRASONICS;

ANEUPLOIDY; DOWN SYNDROME; GENETIC SONOGRAM; LIKELIHOOD RATIOS; SEQUENTIAL TESTING; SONOGRAPHIC EXAMINATIONS; SONOGRAPHIC FINDINGS; STEPWISE SEQUENTIAL;

OBSTETRICS;

ANEUPLOIDY; ANTENATAL SCREENING; ARTICLE; COHORT ANALYSIS; DOWN SYNDROME; DOWN SYNDROME SCREENING; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; GENETIC PREDISPOSITION; GENETIC SONOGRAM; GENETICS; HUMAN; MALE; MASS SCREENING; METHODOLOGY; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STATISTICS; STEPWISE SEQUENTIAL; UNITED STATES; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ANEUPLOIDY; ANTENATAL SCREENING; DOWN SYNDROME SCREENING; GENETIC SONOGRAM; STEPWISE SEQUENTIAL;

COHORT STUDIES; CONNECTICUT; DOWN SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84883339574     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.9.1607     Document Type: Article

References (19)

1. Antenatal diagnosis; amniocentesis. NIH consensus Development Conferences. Clin Pediatr (Phila) 1979; 18:454-462.
2. Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006; 195:109-114.
3. Borrell A, Gonce A, Martinez JM, et al. First-trimester screening for Down's syndrome with ductus venosus in Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn2005; 25:901-905.
4. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005; 26:22-27.
5. Sonek J, Borenstein M, Dagklis T, Persico N, Nicolaides KH. Frontomaxillary facial angle in fetuses with trisomy 21 at 11-13(6) weeks. Am J Obstet Gynecol 2007; 196:1-4.
6. Benn P, Borrell A, Crossley J, et al. Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenat Diagn2011; 31:519-522.
7. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109:217-227.
8. Malone FD, Canick JA, Ball RH, et al; First-And Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353:2001-2011.
9. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 2004; 24:762-766.
10. Benn PA, Campbell WA, Zelop CM, Ingardia C, Egan JF. Stepwise sequential screening for fetal aneuploidy. Am J Obstet Gynecol 2007; 197:312.e1-312.e5.
11. Aagaard-Tillery KM, Malone FD, Nyberg DA, et al. Role of secondtrimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009; 114:1189-1196.
12. Benn PA, Egan JF. Expected performance of second trimester maternal serum testing followed by a "genetic sonogram" in screening of fetal Down syndrome. Prenat Diagn 2008; 28:230-235.
13. American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 2010; 29:157-166.
14. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Ageadjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998; 12:8-14.
15. DeVore GR. Genetic sonography: the historical and clinical role of fetal echocardiography. Ultrasound Obstet Gynecol 2010; 35:509-521.
16. Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH. Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol 2007; 109:1046-1052.
17. Egan JFX, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. Antenatal Down syndrome screening in the US in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol2003; 187:1230-1234.
18. Fang YM, Benn P, Egan JF. Use of the genetic sonogram in the United States in 2001 and 2007. J Ultrasound Med 2008; 27:1543-1548.
19. Morris JK, Alberman E. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. BMJ 2009; 339:b3794.